Patent · US Active

Modified stem cell memory T cells, methods of making and methods of using same

US10415016B2 · kind B2 · utility

3Cited by

32References

22Claims

0Family size

Assignee

Poseida Therapeutics, Inc. · US

Inventors

Eric M. Ostertag · San Diego, US
Devon Shedlock · San Diego, US

Key dates

Filing date	Jan 31, 2018
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Jan 31, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides a method of producing modified stem memory T cells (e.g. CAR-T cells) for administration to a subject as, for example an adoptive cell therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.